GBS is an acute immune-mediated neuropathy and a leading cause of acute flaccid paralysis in children. Although intravenous immunoglobulin and plasmapheresis are established treatments, data comparing their outcomes and prognostic factors in pediatric patients remain limited.Objective: To evaluate clinical characteristics, treatment modalities, and prognostic factors in pediatric GBS, with a focus on functional outcomes assessed by the Hughes disability score.Methods: This retrospective observational study included children diagnosed with GBS and treated with either IVIG alone or IVIG combined with plasmapheresis. Demographic features, clinical presentation, antecedent infections, cerebrospinal fluid protein levels, electrophysiological subtypes, lumbar MRI findings, rehabilitation duration, PICU admission, mechanical ventilation requirement, and neurological sequelae were analyzed. Functional status was assessed using the Hughes disability scale at admission and at 3 months. Correlation analyses were performed to evaluate associations between Hughes scores and clinical parameters.Results: Thirty-two pediatric patients were included; 27 received IVIG alone and 5 received IVIG plus plasmapheresis. No significant differences were observed between treatment groups regarding age, CSF protein levels, or rehabilitation duration, although rehabilitation tended to be longer in the combination therapy group. PICU admission and mechanical ventilation occurred exclusively in patients receiving IVIG plus plasmapheresis. At 3 months, patients with Hughes scores >2 had significantly higher rates of residual neurological deficits (75% vs. 0%, p=0.001). Rehabilitation duration showed a strong positive correlation with the 3-month Hughes score (r=0.737, p=0.001).Conclusion: Higher 3-month Hughes scores were associated with residual neurological deficits and longer rehabilitation duration. Treatment modality was not independently associated with short-term functional outcome.